Skip to main content

Letter: HPV vaccine provides cancer prevention

To the editor: Last year, the Shawano-Menominee Counties Health Department was awarded a grant from the Wisconsin Comprehensive Cancer Control Program to bring information about the HPV vaccine to the public and health care providers. Human Papilloma Virus is the most common sexually transmitted infection in the United States. The Centers for Disease Control and Prevention estimates that nearly 80 million adults, roughly one in four, are currently infected with HPV. While most HPV infections go away on their own, a few types of the virus can cause serious health problems, including cancer. There are many types of cancer caused by HPV, including cervical cancer in women and oropharyngeal cancer in men and women. Every year 27,000 men and women in the U.S. develop cancer caused by HPV. That number is expected to increase in the coming years as the Baby Boomer and Generation X populations age. There is no way to predict who will develop cancer from HPV infection, but there is a way to help prevent cancer caused by HPV — the HPV vaccine. The HPV vaccine was created as a mechanism to prevent cancers caused by HPV infection. The vaccine is designed to be given when kids are young, 11-12 years old. Current evidence recommends males can receive the vaccine through age 21 and females through age 26. It is better to get the vaccine early, before becoming sexually active and at risk for HPV infection. This is to make sure the vaccine is able to develop its fullest immunity (preventing HPV infection from taking place once a person does become sexually active). The HPV vaccine is safe. The U.S. Food and Drug Administration tested thousands of people for side effects before approving the vaccine and studies have continued to test the safety of the vaccine. From June 2006 through September 2015 about 80 million doses of Gardasil (the most commonly used HPV vaccine) were given in the U.S. Less than 1 percent of doses given have caused side effects, nearly all of which have been minor. The HPV vaccine does not contain mercury, and you won’t get HPV from the vaccine. In the 10 years since the vaccine has been available, a lot of research has focused on the vaccine’s effectiveness. In 2012, the CDC found that HPV vaccine use had cut rates of HPV infection by half among female teenagers and by one third in female adults. The vaccine is also showing impact on preventing many forms of cancer. Nearly 100 percent of cervical cancer is caused by HPV. Cervical screenings, called Pap smears, are used to identify early stages of cervical disease and women at risk for developing cervical cancer. The HPV vaccine has been shown to reduce the incidence of abnormal (or at risk) pap smears by 95 percent when administered before beginning sexual activity. This means that the future potential for vaccinated women to develop cervical cancer is significantly decreased now and in their future. Talk to your health care provider about the HPV vaccine for your children. The vaccine is given in three doses over a six-month period for its full effect to be achieved. Even if your children are older than 11 or 12 years, completing the vaccine series can have important benefits for their future. The HPV vaccine is cancer prevention! Jaime Bodden, Health Officer, Deborah Zernicke, Public Health Nursing Supervisor, Kristine Labby, Public Health Nurse, Judith Sengstock, Public Health Nurse Shawano-Menominee Counties Health Department